DOCSLIB.ORG

Genetic Network Regulating Visual Acuity Makes Limited Contribution

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genetic Network Regulating Visual Acuity Makes Limited Contribution bioRxiv preprint doi: https://doi.org/10.1101/2021.05.04.442661; this version posted May 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Genetic network regulating visual acuity makes limited contribution 2 to visually guided eye emmetropization 3 4 5 Tatiana V. Tkatchenko1 and Andrei V. Tkatchenko1,2* 6 7 8 1Department of Ophthalmology, Columbia University, New York, New York, USA; 9 3Department of Pathology and Cell Biology, Columbia University, New York, New York, USA 10 11 Tatiana V. Tkatchenko, E-mail: [email protected] 12 Andrei V. Tkatchenko, E-mail: [email protected] 13 14 15 16 17 18 RNA-seq data from this article have been deposited in the Gene Expression Omnibus database 19 under accession No. GSE158732 20 21 *Correspondence to: Andrei V. Tkatchenko, Edward S. Harkness Eye Institute, Research 22 Annex Room 415, 635 W. 165th Street, New York, NY 10032, USA. Phone: 212-342-5135; 23 Fax: 212-342-0094; E-mail: [email protected] Page 1 of 40 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.04.442661; this version posted May 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 24 Abstract 25 During postnatal development, the eye undergoes a refinement process whereby optical defocus 26 guides eye growth towards sharp vision in a process of emmetropization. Optical defocus 27 activates a signaling cascade originating in the retina and propagating across the back of the eye 28 to the sclera. Several observations suggest that visual acuity might be important for optical 29 defocus detection and processing in the retina; however, direct experimental evidence supporting 30 or refuting the role of visual acuity in refractive eye development is lacking. Here, we used 31 genome-wide transcriptomics to determine the relative contribution of the retinal genetic 32 network regulating visual acuity to the signaling cascade underlying visually guided eye 33 emmetropization. 34 Our results provide evidence that visual acuity is regulated at the level of molecular signaling in 35 the retina by an extensive genetic network. The genetic network regulating visual acuity makes 36 relatively small contribution to the signaling cascade underlying refractive eye development. 37 This genetic network primarily affects baseline refractive eye development and this influence is 38 primarily facilitated by the biological processes related to melatonin signaling, nitric oxide 39 signaling, phototransduction, synaptic transmission, and dopamine signaling. We also observed 40 that the visual-acuity-related genes associated with the development of human myopia are 41 chiefly involved in light perception and phototransduction. Our results suggest that the visual- 42 acuity-related genetic network primarily contributes to the signaling underlying baseline 43 refractive eye development, whereas its impact on visually guided eye emmetropization is 44 modest. 45 Page 2 of 40 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.04.442661; this version posted May 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 46 Keywords: Refractive eye development, Emmetropization, Optical defocus, Visual acuity, 47 Signaling pathways, Gene expression profiling, Gene expression networks, RNA-seq. 48 49 Abbreviations 50 AMPK: AMP-activated protein kinase; ANOVA: analysis of variance; ARVO: Association for 51 Research in Vision and Ophthalmology; CACNA2D1: calcium voltage-gated channel auxiliary 52 subunit alpha2 delta 1; CAMK2G: calcium/calmodulin dependent protein kinase II gamma; 53 CB2R: cannabinoid receptor type 2; CFH: complement factor H; CNGB3: cyclic nucleotide 54 gated channel subunit beta 3; cpd: cycles per degree; DARPP32: protein phosphatase 1 55 regulatory inhibitor subunit 1B; DAVID: database for annotation, visualization and integrated 56 discovery; GP6: glycoprotein VI platelet; GRK1: G protein-coupled receptor kinase 1; GWAS: 57 genome-wide association study; IMPG2: interphotoreceptor matrix proteoglycan 2; IPA: 58 Ingenuity Pathway Analysis; JAK2: Janus kinase 2; LED: light-emitting diode; LRIT1: leucine 59 rich repeat, Ig-like and transmembrane domains 1; mTOR: mammalian target of rapamycin; 60 nNOS: neuronal nitric oxide synthase; OMIM: Online Mendelian Inheritance in Man database; 61 OR: odds ratio; PDE6A: phosphodiesterase 6A; PDE6C: phosphodiesterase 6C; PPARα: 62 Peroxisome proliferator-activated receptor alpha; PTEN: phosphatase and tensin homolog; RAR: 63 retinoic acid receptor; RCB: randomized complete block; RDH12: retinol dehydrogenase 12; 64 RhoGDI: Rho GDP-dissociation inhibitor; RIN: RNA integrity number; RNA-seq: massive 65 parallel RNA sequencing; RXRα: retinoid X receptor alpha; SNP: single-nucleotide 66 polymorphism; QTL: quantitative trait locus; VEP: visually evoked potential; 67 Page 3 of 40 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.04.442661; this version posted May 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 68 1. Introduction 69 The general layout of the eye is established during embryonic development; however, the eye 70 undergoes a refinement process during postnatal period, whereby the optical geometry of the eye 71 and its refractive state are guided towards sharp vision in a process called emmetropization [1-8]. 72 Various environmental factors influence refractive eye development during emmetropization [8- 73 11]; however, the leading environmental factor guiding refractive eye development is optical 74 defocus [8, 12]. The eye is very sensitive to the sign of optical defocus and can accurately 75 compensate for imposed defocus by modulating the growth of the posterior segment of the eye 76 [12-18]. Emmetropization uses optical defocus to match the eye’s axial length to its focal plane 77 and normally produces emmetropia (sharp vision) [8]. Prolonged exposure to positive optical 78 defocus leads to the development of hyperopia (farsightedness), whereas excessive exposure to 79 negative optical defocus leads to the development of myopia (nearsightedness) [13, 14, 16-27]. 80 The role of optical defocus in eye emmetropization is well established [8]. It was also found that 81 molecular signaling underlying retinal response to positive and negative defocus propagate along 82 two largely distinct signaling cascades [12]. Genetic networks underlying baseline refractive eye 83 development and visually guided eye emmetropization are also beginning to come to light [8, 28, 84 29]. However, the molecular cascade responsible for the detection and processing of optical 85 defocus by the eye is still poorly understood. We have recently found that the gene expression 86 network subserving perception of contrast plays an important role in optical defocus detection 87 and visually guided eye emmetropization [30]; however, the role of visual acuity in optical 88 defocus detection and emmetropization remains a subject of debate. 89 Visual acuity is primarily determined by the density of photoreceptors in the central 90 retina and declines sharply with increasing retinal eccentricity [31, 32]. Several lines of evidence Page 4 of 40 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.04.442661; this version posted May 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 91 suggest that the absolute level of visual acuity does not play a significant role in optical defocus 92 detection and emmetropization because species with different levels of visual acuity ranging 93 from 1.3 cycles per degree (cpd) in fish [33], 0.6-1.4 cpd in mice [34-36], 2.4 cpd in tree shrews 94 [37, 38], 2.7 cpd in guinea pigs [39, 40], 5 cpd in cats [41, 42], 5 cpd chickens [43, 44] and 44 95 cpd in rhesus monkeys and humans [45-47] undergo emmetropization and can compensate for 96 imposed optical defocus [13-17, 48-52]. Interestingly, visual acuity in newborn human infants 97 during first months of life, i.e., when they undergo most active eye emmetropization, remains 98 low, 2.4 cpd in 1-month-old infants gradually increasing to 10-15 cpd in 8-month-olds [47, 53, 99 54]. In agreement with these observations, Mutti et al. found that emmetropization in infants 100 does not appear to be dependent on visual acuity [55]. Studies in a mutant chicken model with 101 diminished visual acuity also revealed that reduced visual acuity had limited impact on 102 susceptibility to either form-deprivation or lens-induced myopia, hence emmetropization [56]. It 103 was also found that accommodation and emmetropization are primarily dependent on low spatial 104 frequencies even in species with high visual acuity [57, 58]; and that the peripheral retina, which 105 has much lower visual acuity than the central retina [32, 53, 59-62], plays an important role in 106 defocus detection and emmetropization [8, 63-65]. Moreover, it was reported that inhibitory 107 inputs to the ganglion cells from the amacrine cells, which are critical for optical defocus 108 detection, are more predominant in the low-resolution peripheral retina, while the high-resolution 109 foveal retinal circuits primarily rely on excitatory inputs [66]. Nevertheless, there is evidence 110 that visual acuity might influence visually guided eye emmetropization. For example, certain 111 mutations affecting visual acuity in humans were also found to be linked to the development of 112 myopia [67]. It was also found that maturation of visually evoked potentials (VEPs), which 113 correlate with sensitivity to optical defocus, shows strong correlation with visual acuity [68]. Page 5 of 40 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.04.442661; this version posted May 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
Load more

Recommended publications
  • Genetic Analysis of Retinopathy in Type 1 Diabetes
    Genetic Analysis of Retinopathy in Type 1 Diabetes by Sayed Mohsen Hosseini A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Institute of Medical Science University of Toronto © Copyright by S. Mohsen Hosseini 2014 Genetic Analysis of Retinopathy in Type 1 Diabetes Sayed Mohsen Hosseini Doctor of Philosophy Institute of Medical Science University of Toronto 2014 Abstract Diabetic retinopathy (DR) is a leading cause of blindness worldwide. Several lines of evidence suggest a genetic contribution to the risk of DR; however, no genetic variant has shown convincing association with DR in genome-wide association studies (GWAS). To identify common polymorphisms associated with DR, meta-GWAS were performed in three type 1 diabetes cohorts of White subjects: Diabetes Complications and Control Trial (DCCT, n=1304), Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR, n=603) and Renin-Angiotensin System Study (RASS, n=239). Severe (SDR) and mild (MDR) retinopathy outcomes were defined based on repeated fundus photographs in each study graded for retinopathy severity on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Multivariable models accounted for glycemia (measured by A1C), diabetes duration and other relevant covariates in the association analyses of additive genotypes with SDR and MDR. Fixed-effects meta- analysis was used to combine the results of GWAS performed separately in WESDR, ii RASS and subgroups of DCCT, defined by cohort and treatment group. Top association signals were prioritized for replication, based on previous supporting knowledge from the literature, followed by replication in three independent white T1D studies: Genesis-GeneDiab (n=502), Steno (n=936) and FinnDiane (n=2194).
    [Show full text]
  • Expanding the Phenotypic Spectrum in RDH12-Associated Retinal Disease
    COLD SPRING HARBOR Molecular Case Studies | RESEARCH REPORT Expanding the phenotypic spectrum in RDH12-associated retinal disease Hilary A. Scott,1 Emily M. Place,1 Kevin Ferenchak,1 Erin Zampaglione,1 Naomi E. Wagner,1 Katherine R. Chao,2 Stephanie P. DiTroia,2 Daniel Navarro-Gomez,1 Shizuo Mukai,3 Rachel M. Huckfeldt,1 Eric A. Pierce,1 and Kinga M. Bujakowska1 1Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts 02114, USA; 2Center for Mendelian Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA; 3Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts 02114, USA Abstract Retinol dehydrogenase 12, RDH12, plays a pivotal role in the visual cycle to ensure the maintenance of normal vision. Alterations in activity of this protein result in photorecep- tor death and decreased vision beginning at an early age and progressing to substantial vi- sion loss later in life. Here we describe 11 patients with retinal degeneration that underwent next-generation sequencing (NGS) with a targeted panel of all currently known inherited retinal degeneration (IRD) genes and whole-exome sequencing to identify the genetic causality of their retinal disease. These patients display a range of phenotypic severity prompting clinical diagnoses of macular dystrophy, cone-rod dystrophy, retinitis pigmento- sa, and early-onset severe retinal dystrophy all attributed to biallelic recessive mutations in RDH12. We report 15 causal alleles and expand the repertoire of known RDH12 mutations with four novel variants: c.215A > G (p.Asp72Gly); c.362T > C (p.Ile121Thr); c.440A > C Correspondence: (p.Asn147Thr); and c.697G > A (p.Val233Ille).
    [Show full text]
  • Gene Expression in the Mouse Eye: an Online Resource for Genetics Using 103 Strains of Mice
    Molecular Vision 2009; 15:1730-1763 <http://www.molvis.org/molvis/v15/a185> © 2009 Molecular Vision Received 3 September 2008 | Accepted 25 August 2009 | Published 31 August 2009 Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice Eldon E. Geisert,1 Lu Lu,2 Natalie E. Freeman-Anderson,1 Justin P. Templeton,1 Mohamed Nassr,1 Xusheng Wang,2 Weikuan Gu,3 Yan Jiao,3 Robert W. Williams2 (First two authors contributed equally to this work) 1Department of Ophthalmology and Center for Vision Research, Memphis, TN; 2Department of Anatomy and Neurobiology and Center for Integrative and Translational Genomics, Memphis, TN; 3Department of Orthopedics, University of Tennessee Health Science Center, Memphis, TN Purpose: Individual differences in patterns of gene expression account for much of the diversity of ocular phenotypes and variation in disease risk. We examined the causes of expression differences, and in their linkage to sequence variants, functional differences, and ocular pathophysiology. Methods: mRNAs from young adult eyes were hybridized to oligomer microarrays (Affymetrix M430v2). Data were embedded in GeneNetwork with millions of single nucleotide polymorphisms, custom array annotation, and information on complementary cellular, functional, and behavioral traits. The data include male and female samples from 28 common strains, 68 BXD recombinant inbred lines, as well as several mutants and knockouts. Results: We provide a fully integrated resource to map, graph, analyze, and test causes and correlations of differences in gene expression in the eye. Covariance in mRNA expression can be used to infer gene function, extract signatures for different cells or tissues, to define molecular networks, and to map quantitative trait loci that produce expression differences.
    [Show full text]
  • Examination of Testicular Gene Expression Patterns in Yorkshire Pigs with High and Low Levels of Boar Taint
    Animal Biotechnology, 21: 77–87, 2010 Copyright # Taylor & Francis Group, LLC ISSN: 1049-5398 print=1532-2378 online DOI: 10.1080/10495390903500607 EXAMINATION OF TESTICULAR GENE EXPRESSION PATTERNS IN YORKSHIRE PIGS WITH HIGH AND LOW LEVELS OF BOAR TAINT Maxwell C. K. Leung, Kiera-Lynne Bowley, and E. James Squires Department of Animal and Poultry Science, University of Guelph, Guelph, Ontario, Canada Boar taint refers to the objectionable odor and flavor in meat of some uncastrated male pigs, which is primarily due to high levels of androstenone, a steroid produced in the testis, and 3-methylindole (skatole) which is produced by bacterial degradation of tryptophan in the intestinal tract. We determined testicular gene expression patterns of Yorkshire pigs with high and low levels of boar taint using swine DNA microarrays with two-color hybridization. The microarrays contained 19486 annotated probes; the expressions of 8719 genes were detected. Fifty-three genes were significantly up-regulated in the high boar taint group and four were significantly down-regulated (p < 0.05; fold change > Æ1.55). Gene ontology (GO) analysis short-listed 11 significant GO terms (p < 0.05), most of which are associated with steroid metabolism and mitochondrial components. Comparing the results of this study with published work on Duroc and Norwegian Landrace boars,1 eleven genes (HSB17B4, FDX1, CYP11A1, DHRS4, PRDX1, CYB5, CYP17A1, FTL, IDI1, SULT2A1, and RDH12) were over-expressed in all three breeds with a high androstenone level. The current findings confirmed a number of candidate genes identified in previous functional studies and suggest several new genes differentially expressed with different levels of boar taint.
    [Show full text]
  • Comparative Analysis of the Domestic Cat Genome Reveals Genetic Signatures Underlying Feline Biology and Domestication
    Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication Michael J. Montaguea,1, Gang Lib,1, Barbara Gandolfic, Razib Khand, Bronwen L. Akene, Steven M. J. Searlee, Patrick Minxa, LaDeana W. Hilliera, Daniel C. Koboldta, Brian W. Davisb, Carlos A. Driscollf, Christina S. Barrf, Kevin Blackistonef, Javier Quilezg, Belen Lorente-Galdosg, Tomas Marques-Bonetg,h, Can Alkani, Gregg W. C. Thomasj, Matthew W. Hahnj, Marilyn Menotti-Raymondk, Stephen J. O’Brienl,m, Richard K. Wilsona, Leslie A. Lyonsc,2, William J. Murphyb,2, and Wesley C. Warrena,2 aThe Genome Institute, Washington University School of Medicine, St. Louis, MO 63108; bDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843; cDepartment of Veterinary Medicine & Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65201; dPopulation Health & Reproduction, School of Veterinary Medicine, University of California, Davis, CA 95616; eWellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; fNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20886; gCatalan Institution for Research and Advanced Studies, Institute of Evolutionary Biology, Pompeu Fabra University, 08003 Barcelona, Spain; hCentro de Analisis Genomico 08028, Barcelona, Spain; iDepartment of Computer Engineering, Bilkent University, Ankara 06800, Turkey; jDepartment of Biology, Indiana University, Bloomington,
    [Show full text]
  • Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
    cells Review Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss 1, 1, 1 1,2,3 1 Gayle B. Collin y, Navdeep Gogna y, Bo Chang , Nattaya Damkham , Jai Pinkney , Lillian F. Hyde 1, Lisa Stone 1 , Jürgen K. Naggert 1 , Patsy M. Nishina 1,* and Mark P. Krebs 1,* 1 The Jackson Laboratory, Bar Harbor, Maine, ME 04609, USA; [email protected] (G.B.C.); [email protected] (N.G.); [email protected] (B.C.); [email protected] (N.D.); [email protected] (J.P.); [email protected] (L.F.H.); [email protected] (L.S.); [email protected] (J.K.N.) 2 Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand 3 Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand * Correspondence: [email protected] (P.M.N.); [email protected] (M.P.K.); Tel.: +1-207-2886-383 (P.M.N.); +1-207-2886-000 (M.P.K.) These authors contributed equally to this work. y Received: 29 February 2020; Accepted: 7 April 2020; Published: 10 April 2020 Abstract: Inherited retinal degeneration (RD) leads to the impairment or loss of vision in millions of individuals worldwide, most frequently due to the loss of photoreceptor (PR) cells. Animal models, particularly the laboratory mouse, have been used to understand the pathogenic mechanisms that underlie PR cell loss and to explore therapies that may prevent, delay, or reverse RD. Here, we reviewed entries in the Mouse Genome Informatics and PubMed databases to compile a comprehensive list of monogenic mouse models in which PR cell loss is demonstrated.
    [Show full text]
  • RDH12 Mutations Cause a Severe Retinal Degeneration with Relatively Spared Rod Function
    Retina RDH12 Mutations Cause a Severe Retinal Degeneration With Relatively Spared Rod Function Tomas S. Aleman,1,2 Katherine E. Uyhazi,1 Leona W. Serrano,1 Vidyullatha Vasireddy,2 Scott J. Bowman,1 Michael J. Ammar,1 Denise J. Pearson,1 Albert M. Maguire,1,2 and Jean Bennett1,2 1Scheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States 2Department of Ophthalmology, Center for Advanced Ocular and Retinal Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States Correspondence: Tomas S. Aleman, PURPOSE. To describe the retinal phenotype of pediatric patients with mutations in the retinol Perelman Center for Advanced Med- dehydrogenase 12 (RDH12) gene. icine, University of Pennsylvania, 3400 Civic Center Boulevard, Phila- METHODS. Twenty-one patients from 14 families (ages 2–17 years) with RDH12-associated delphia, PA 19104, USA; inherited retinal degeneration (RDH12-IRD) underwent a complete ophthalmic exam and [email protected]. imaging with spectral domain optical coherence tomography (SD-OCT) and near infrared and TSA and KEU are joint first authors. short-wavelength fundus autofluorescence. Visual field extent was measured with Goldmann kinetic perimetry, visual thresholds with dark-adapted static perimetry or with dark-adapted Submitted: May 29, 2018 chromatic full-field stimulus testing (FST) and transient pupillometry. Accepted: August 29, 2018 RESULTS. Visual acuity ranged from 20/40 to light perception. There was parafoveal Citation: Aleman TS, Uyhazi KE, Ser- rano LW, et al. RDH12 mutations depigmentation or atrophic maculopathies accompanied by midperipheral intraretinal cause a severe retinal degeneration pigment migration. SD-OCT revealed foveal thinning in all patients and detectable but with relatively spared rod function.
    [Show full text]
  • Comprehensive Genotyping Reveals RPE65 As the Most Frequently Mutated Gene in Leber Congenital Amaurosis in Denmark
    European Journal of Human Genetics (2016) 24, 1071–1079 & 2016 Macmillan Publishers Limited All rights reserved 1018-4813/16 www.nature.com/ejhg ARTICLE Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark Galuh DN Astuti1,2,3,10, Mette Bertelsen4,5,6,10, Markus N Preising7, Muhammad Ajmal8, Birgit Lorenz7, Sultana MH Faradz3, Raheel Qamar8,9, Rob WJ Collin1,2, Thomas Rosenberg4,6 and Frans PM Cremers*,1,2,8 Leber congenital amaurosis (LCA) represents the most severe form of inherited retinal dystrophies with an onset during the first year of life. Currently, 21 genes are known to be associated with LCA and recurrent mutations have been observed in AIPL1, CEP290, CRB1 and GUCY2D. In addition, sequence analysis of LRAT and RPE65 may be important in view of treatments that are emerging for patients carrying variants in these genes. Screening of the aforementioned variants and genes was performed in 64 Danish LCA probands. Upon the identification of heterozygous variants, Sanger sequencing was performed of the relevant genes to identify the second allele. In combination with prior arrayed primer extension analysis, this led to the identification of two variants in 42 of 86 cases (49%). Remarkably, biallelic RPE65 variants were identified in 16% of the cases, and one novel variant, p.(D110G), was found in seven RPE65 alleles. We also collected all previously published RPE65 variants, identified in 914 alleles of 539 patients with LCA or early-onset retinitis pigmentosa, and deposited them in the RPE65 Leiden Open Variation Database (LOVD). The in silico pathogenicity assessment of the missense and noncanonical splice site variants, as well as an analysis of their frequency in ~ 60 000 control individuals, rendered 864 of the alleles to affect function or probably affect function.
    [Show full text]
  • Involvement of Oxidative and Endoplasmic Reticulum Stress in RDH12-Related Retinopathies
    International Journal of Molecular Sciences Article Involvement of Oxidative and Endoplasmic Reticulum Stress in RDH12-Related Retinopathies Hajrah Sarkar 1,2, Maria Toms 1,2 and Mariya Moosajee 1,2,3,4,* 1 Institute of Ophthalmology, University College London, London EC1V 9EL, UK; [email protected] (H.S.); [email protected] (M.T.) 2 The Francis Crick Institute, London NW1 1AT, UK 3 Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK 4 Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK * Correspondence: [email protected] Abstract: Retinol dehydrogenase 12 (RDH12) is expressed in photoreceptor inner segments and catalyses the reduction of all-trans retinal (atRAL) to all-trans retinol (atROL), as part of the visual cycle. Mutations in RDH12 are primarily associated with autosomal recessive Leber congenital amaurosis. To further our understanding of the disease mechanisms, HEK-293 cell lines expressing wildtype (WT) and mutant RDH12 were created. The WT cells afforded protection from atRAL- induced toxicity and oxidative stress. Mutant RDH12 cells displayed reduced protein expression and activity, with an inability to protect cells from atRAL toxicity, inducing oxidative and endoplasmic reticulum (ER) stress, with upregulation of sXBP1, CHOP, and ATF4. Pregabalin, a retinal scavenger, attenuated atRAL-induced ER stress in the mutant RDH12 cell lines. A zebrafish rdh12 mutant model (rdh12u533 c.17_23del; p.(Val6AlafsTer5)) was generated through CRISPR-Cas9 gene editing. Mutant Citation: Sarkar, H.; Toms, M.; fish showed disrupted phagocytosis through transmission electron microscopy, with increased Moosajee, M. Involvement of phagosome size at 12 months post-fertilisation.
    [Show full text]
  • Determining the Causes of Recessive Retinal Dystrophy
    Determining the causes of recessive retinal dystrophy By Mohammed El-Sayed Mohammed El-Asrag BSc (hons), MSc (hons) Genetics and Molecular Biology Submitted in accordance with the requirements for the degree of Doctor of Philosophy The University of Leeds School of Medicine September 2016 The candidate confirms that the work submitted is his own, except where work which has formed part of jointly- authored publications has been included. The contribution of the candidate and the other authors to this work has been explicitly indicated overleaf. The candidate confirms that appropriate credit has been given within the thesis where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Mohammed El-Sayed Mohammed El-Asrag to be identified as author of this work has been asserted by his in accordance with the Copyright, Designs and Patents Act 1988. © 2016 The University of Leeds and Mohammed El-Sayed Mohammed El-Asrag Jointly authored publications statement Chapter 3 (first results chapter) of this thesis is entirely the work of the author and appears in: Watson CM*, El-Asrag ME*, Parry DA, Morgan JE, Logan CV, Carr IM, Sheridan E, Charlton R, Johnson CA, Taylor G, Toomes C, McKibbin M, Inglehearn CF and Ali M (2014). Mutation screening of retinal dystrophy patients by targeted capture from tagged pooled DNAs and next generation sequencing. PLoS One 9(8): e104281. *Equal first- authors. Shevach E, Ali M, Mizrahi-Meissonnier L, McKibbin M, El-Asrag ME, Watson CM, Inglehearn CF, Ben-Yosef T, Blumenfeld A, Jalas C, Banin E and Sharon D (2015).
    [Show full text]
  • Development of Gene Therapy for the Treatment of Retinal Dystrophies Caused by Mutations in AIPL1
    Development of Gene Therapy for the Treatment of Retinal Dystrophies caused by mutations in AIPL1 Mei Hong Tan A thesis submitted for the degree of Doctor of Philosophy 2011 Department of Genetics Institute of Ophthalmology University College London 1 Declaration I, Mei Hong Tan confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. ............................................... DATE: ................................... 2 Abstract Genetic defects in AIPL1 cause a heterogeneous set of clinical conditions depending on the severity of the mutant alleles. Diseases can range from Leber Congenital Amaurosis (LCA), the severest form of early-onset retinal degeneration, to milder forms such as retinitis pigmentosa (RP) and cone-rod dystrophy. There is currently no effective treatment for LCA and inherited retinal dystrophies, which are the commonest cause of childhood blindness. AIPL1 is expressed primarily in retinal photoreceptors and is required for the biosynthesis of photoreceptor phosphodiesterase (PDE). This thesis describes a programme of work that examines the potential and efficacy of gene replacement therapy in the treatment of AIPL1- associated retinal diseases. It centres on the use of recombinant adeno-associated virus for the transfer of murine and human AIPL1 cDNA into photoreceptor cells. AAV-mediated gene replacement was assessed in two genetically engineered mouse models carrying null and hypomorphic alleles, Aipl1 -/- and Aipl1 h/h mice, which simulate retinal degenerations similar to human LCA and RP respectively. Three different rates of photoreceptor degeneration were simulated using the mouse models. To treat the different rates of degeneration, two pseudotypes of AAV (serotype 2 and 8) exhibiting different transduction kinetics were used for gene transfer.
    [Show full text]
  • Chromosome 14 Deletions, Rings, and Epilepsy Genes: a Riddle Wrapped in a Mystery Inside an Enigma
    Received: 24 June 2020 | Revised: 16 October 2020 | Accepted: 16 October 2020 DOI: 10.1111/epi.16754 CRITICAL REVIEW – INVITED COMMENTARY Chromosome 14 deletions, rings, and epilepsy genes: A riddle wrapped in a mystery inside an enigma Alessandro Vaisfeld1 | Serena Spartano1 | Giuseppe Gobbi2 | Annamaria Vezzani3 | Giovanni Neri1,4 1Institute of Genomic Medicine, Catholic University School of Medicine, Rome, Italy Abstract 2Residential Center for Rehabilitation Luce The ring 14 syndrome is a rare condition caused by the rearrangement of one chromo- Sul Mare, Rimini, Italy some 14 into a ring-like structure. The formation of the ring requires two breakpoints 3 Department of Neuroscience, IRCCS- and loss of material from the short and long arms of the chromosome. Like many Istituto di Ricerche Farmacologiche Mario other chromosome syndromes, it is characterized by multiple congenital anomalies Negri, Milano, Italy 4J.C. Self Research Institute, Greenwood and developmental delays. Typical of the condition are retinal anomalies and drug- Genetic Center, Greenwood, SC, USA resistant epilepsy. These latter manifestations are not found in individuals who are carriers of comparable 14q deletions without formation of a ring (linear deletions). Correspondence Giovanni Neri, Institute of Genomic To find an explanation for this apparent discrepancy and gain insight into the mecha- Medicine, Catholic University School of nisms leading to seizures, we reviewed and compared literature cases of both ring Medicine, Rome, Italy. and linear deletion syndrome with respect to both their clinical manifestations and Email: [email protected] the role and function of potentially epileptogenic genes. Knowledge of the epilepsy- Funding information related genes in chromosome 14 is an important premise for the search of new and Ring 14 International; Ring14 Italia effective drugs to combat seizures.
    [Show full text]